Warfarin anticoagulation in children: is there a role for a personalized approach to dosing?

Pharmacogenomics. 2012 Aug;13(11):1211-4. doi: 10.2217/pgs.12.92.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adolescent
  • Anticoagulants / administration & dosage*
  • Aryl Hydrocarbon Hydroxylases / genetics
  • Biomarkers, Pharmacological
  • Blood Coagulation / drug effects*
  • Child
  • Child, Preschool
  • Cytochrome P-450 CYP2C9
  • Dose-Response Relationship, Drug
  • Humans
  • Infant
  • International Normalized Ratio
  • Mixed Function Oxygenases / genetics
  • Polymorphism, Genetic
  • Vitamin K Epoxide Reductases
  • Warfarin / administration & dosage*

Substances

  • Anticoagulants
  • Biomarkers, Pharmacological
  • Warfarin
  • Mixed Function Oxygenases
  • CYP2C9 protein, human
  • Cytochrome P-450 CYP2C9
  • Aryl Hydrocarbon Hydroxylases
  • Vitamin K Epoxide Reductases